Drug
ceftobiprole medocaril sodium
Marketed as ZEVTERA.
Generic name
ceftobiprole medocaril sodium
Brand names
ZEVTERA
First FDA approval
2024-04-03
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA218275 | ZEVTERA | 2024-04-03 | ISTX |
Manufacturers
ISTX
Frequently asked questions
When was ceftobiprole medocaril sodium FDA approved?
Earliest FDA approval on record: 2024-04-03.
What brand names are sold as ceftobiprole medocaril sodium?
ZEVTERA.
Sources
Appeal a ceftobiprole medocaril sodium denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com